New genes associated with schizophrenia in neurite formation: a review of cell culture experiments

被引:61
作者
Bellon, A. [1 ]
机构
[1] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA
关键词
neuropil; development; NRG1; Akt; DISC-1; dysbindin-1;
D O I
10.1038/sj.mp.4001985
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
New genes consistently associated with schizophrenia include NRG1, Akt, DISC-1 and dysbindin-1. Since these genes participate in neurotransmission, neuroplasticity and neurodevelopment it has not been easy to elucidate which of these roles are abnormal in patients with schizophrenia. Neurite formation is identified as a crucial stage in development, and it is proposed that a defect in neurite formation originating from abnormally encoded proteins by these new genes could be at least an in vitro marker that reflects the most consistent molecular and neuroanatomical findings in schizophrenia. A systematic review of the literature linking the process of neurite formation to genes with replicated evidence that supported their association with schizophrenia was conducted. In addition, an outline of the process of neurite formation was included. Neurite formation was shown to be induced by neuregulins, the product of the gene NRG1. The activation of Akt, a serine/threonine kinase, promoted neurite formation in six independent studies. Conversely, two studies found that Akt inhibits neurite outgrowth. Stronger evidence supporting an association with the new genes related to schizophrenia and neurite formation comes from DISC-1. Defects in DISC-1 protein were shown to directly alter the process of neurite formation. Dysbindin-1 has not yet been directly implicated in neurite outgrowth. These findings suggest that the proteins encoded by NRG1, Akt and DISC-1 are implicated in the process of neurite formation in cellular models as well as, at least in part, animal models during development. Abnormalities in this process could have potential etiologic implications for schizophrenia. Direct evidence, however, of abnormal neurite formation in patients with schizophrenia is still missing. Limitations to this model are identified.
引用
收藏
页码:620 / 629
页数:10
相关论文
共 172 条
[51]   PROJECTIONS OF CELLS IN DIFFERENT LAYERS OF CATS VISUAL-CORTEX [J].
GILBERT, CD ;
KELLY, JP .
JOURNAL OF COMPARATIVE NEUROLOGY, 1975, 163 (01) :81-105
[52]   Prenatal infection and risk for schizophrenia:: IL-Iβ, IL-6, and TNFα inhibit cortical neuron dendrite development [J].
Gilmore, JH ;
Jarskog, LF ;
Vadlamudi, S ;
Lauder, J .
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (07) :1221-1229
[53]   How does an axon grow? [J].
Goldberg, JL .
GENES & DEVELOPMENT, 2003, 17 (08) :941-958
[54]   ESTABLISHMENT OF A NORADRENERGIC CLONAL LINE OF RAT ADRENAL PHEOCHROMOCYTOMA CELLS WHICH RESPOND TO NERVE GROWTH-FACTOR [J].
GREENE, LA ;
TISCHLER, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (07) :2424-2428
[55]  
GUR RE, 1994, AM J PSYCHIAT, V151, P343
[56]   Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia [J].
Hakak, Y ;
Walker, JR ;
Li, C ;
Wong, WH ;
Davis, KL ;
Buxbaum, JD ;
Haroutunian, V ;
Fienberg, AA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) :4746-4751
[57]   Getting our AKT together in schizophrenia? [J].
Hallmayer, J .
NATURE GENETICS, 2004, 36 (02) :115-116
[58]   MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction [J].
Harada, A ;
Teng, JL ;
Takei, Y ;
Oguchi, K ;
Hirokawa, N .
JOURNAL OF CELL BIOLOGY, 2002, 158 (03) :541-549
[59]   TRIIODOTHYRONINE (T3) INDUCES NEURITE FORMATION AND INCREASES SYNTHESIS OF A PROTEIN RELATED TO MAP 1B IN CULTURED-CELLS OF NEURONAL ORIGIN [J].
HARGREAVES, A ;
YUSTA, B ;
ARANDA, A ;
AVILA, J ;
PASCUAL, A .
DEVELOPMENTAL BRAIN RESEARCH, 1988, 38 (01) :141-148
[60]   Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence [J].
Harrison, PJ ;
Weinberger, DR .
MOLECULAR PSYCHIATRY, 2005, 10 (01) :40-68